China Vendor Neutral Archive (VNA) & PACS Market (2026-2031)
The China Vendor Neutral Archive (VNA) & PACS Market was valued at $186.1 Million in 2026 and projected to reach to $317.3 Million by 2031, representing a compound annual growth rate of 11.3%. China's VNA and PACS market is positioned for exceptional growth through 2031, fueled by government investments in healthcare digitalization and the expansion of medical imaging services across tier-2 and tier-3 cities.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
China Vendor Neutral Archive (VNA) & PACS Market Trends and Insights
- This 11.3% compound annual growth rate significantly outpaces global trends, reflecting China's accelerating digital health transformation and substantial investments in healthcare infrastructure modernization.
- China's large patient population, coupled with government mandates for interoperable medical imaging systems, is driving rapid adoption of VNA and PACS solutions across hospitals and diagnostic centers. The market growth in China is underpinned by increasing healthcare digitalization initiatives and the shift toward cloud-based imaging archives.
- China's healthcare providers are prioritizing vendor-neutral solutions to reduce vendor lock-in and improve operational efficiency across multi-site networks.
- The forecast period through 2031 demonstrates China's commitment to standardized, scalable imaging infrastructure that supports both urban and emerging regional healthcare systems. China's competitive landscape features both international vendors and domestic players adapting solutions to local regulatory requirements and clinical workflows.
- The market's expansion reflects broader healthcare IT investments and China's strategic focus on achieving healthcare equity through technology-enabled diagnostic capabilities..
Key Market Statistics
- CAGR (2026-2031) 11.3% CAGR
- Market Size, 2026 ~USD 186.1 Million
- Forecast, 2031 ~USD 317.3 Million
- Country China
China Vendor Neutral Archive (VNA) & PACS Market Overview
Rapid Market Expansion :
China's VNA and PACS market is growing at 11.3% CAGR, significantly outpacing the global rate of 8.9%, driven by aggressive digital health initiatives and government-mandated healthcare modernization across urban and rural regions.
Substantial Market Valuation :
The market is valued at $186.1 million in 2026 and projected to reach $317.3 million by 2031, representing a 70.4% increase over five years as China prioritizes medical imaging infrastructure upgrades.
Government-Backed Digital Health Transformation :
China's national healthcare policies emphasizing interoperability, data standardization, and cloud-based medical imaging solutions are accelerating VNA and PACS adoption across hospitals, clinics, and diagnostic centers nationwide.
Large Patient Population Driving Demand :
With over 1.4 billion residents and increasing healthcare accessibility initiatives, China's vast patient base generates substantial imaging volumes, creating critical demand for efficient archival and picture archiving systems.
China Vendor Neutral Archive (VNA) & PACS Market Dynamics
- The shift toward cloud-based solutions and vendor-neutral architectures aligns with China's broader digital health ecosystem development, enabling seamless data integration across healthcare providers.
- Increasing adoption of AI-powered diagnostic tools and telemedicine platforms further accelerates demand for robust archival infrastructure.
- Healthcare institutions are prioritizing interoperability and cost-efficiency, making VNA solutions increasingly attractive compared to proprietary PACS systems.
- This trajectory positions China as a critical growth engine for the global VNA and PACS market..
Related Ecosystem
Diagnostic Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- CT Scanners
- Nuclear Imaging
- Positron Emission Tomography
- Siemens healthineers
- PHILIPS HEALTHCARE
- CANON INC.
- FUJIFILM Holdings Corporation
- UNITED IMAGING HEALTHCARE CO., LTD.
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- China's VNA & PACS market is valued at $186.1 million in 2026, with projected growth to $317.3 million by 2031, representing an 11.3% CAGR.
- China's healthcare digitalization initiatives and government interoperability mandates are primary drivers accelerating vendor-neutral archive adoption.
- China's large patient base and multi-site hospital networks create significant demand for scalable, cloud-based imaging solutions.
- China's market features competitive dynamics between international vendors and domestic players adapting to local regulatory and clinical requirements.
Vendor Neutral Archive (VNA) & PACS Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | INDIA (Modality) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 8.9% from 2026 to 2031 |
| Largest Segment | VNA (Product Type) |
| Market Size Base Year (Billions) | ~USD 5.6 (2026) |
| Revenue Forecast (Billions) | ~USD 8.57 (2031) |
| Segments Covered | Product Type, Modality, Deployment Model, Type, Vendor Type, Application, End User, Type 2023–2030 |
China Vendor Neutral Archive (VNA) & PACS Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product Type
- Department Vna
- Multi-Department Vna
- Multi-Site Vna
- Pacs
- Vna
By Modality
- Ct
- Mammography
- Mri
- Pet
- Ultrasound
- X-Ray
By Deployment Model
- Cloud-Based Deployment Model
- Cloud-Based Deployment Models
- Hybrid Deployment Models
- On-Premises Deployment Models
By Type
- Department Pacs
- Department Vna
- Multi-Department Pacs
- Multi-Department Vna
- Multi-Site Pacs
- Multi-Site Vna
By Vendor Type
- Independent Vendors
- Third-Party Vendors
By Application
- Cardiology
- Neurology
- Obstetrics & Gynecology
- Oncology
- Orthopedic
- Other Applications
By End User
- Ambulatory Surgery Centers
- Diagnostic Centers
- Hospitals & Clinics
- Other End Users
By Type 2023–2030
- Department Vna
- Multi-Department Vna
- Multi-Site Vna
Target Audience
- Healthcare IT Vendors : VNA and PACS solution providers need China-specific market data to develop localized strategies, identify partnership opportunities, and optimize product offerings for China's regulatory requirements and customer preferences.
- Hospital & Healthcare Networks : Chinese hospital administrators and IT directors require market insights to evaluate VNA and PACS solutions, benchmark against peers, and make informed procurement decisions aligned with national digital health mandates.
- Investment & Private Equity Firms : Investors targeting China's healthcare IT sector need validated market sizing, growth projections, and competitive dynamics to assess investment opportunities and portfolio company valuations in the VNA and PACS space.
- Healthcare Consultants & System Integrators : Consulting firms advising Chinese healthcare institutions on digital transformation require detailed market analysis to recommend appropriate VNA and PACS solutions and develop implementation roadmaps.
- Government & Policy Makers : Chinese healthcare policy officials and government agencies benefit from market intelligence to evaluate digital health initiative effectiveness, identify infrastructure gaps, and guide future healthcare IT investment priorities.
Key Companies in the China Vendor Neutral Archive (VNA) & PACS Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| AGFA-GEVAERT GROUP | Belgium | Public Company | Healthcare enterprise imaging platform and software,Diagnostic imaging hardware, X-ray and hardcopy film, and DR equipment,Sign & display and packaging printers, inks, and software, |
| FUJIFILM HOLDINGS CORPORATION | Japan | Public Company | Healthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductor, storage, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications), |
| SECTRA AB | Sweden | Public Company | Imaging IT Solutions (enterprise imaging, PACS/VNA, services),Secure Communications,Business Innovation (orthopedics, medical education, precision diagnostics IT), |
| GE HEALTHCARE | United States | Public Company | Imaging (CT, MR, X-ray, Molecular, Women’s Health),Advanced Visualization Solutions & Ultrasound / Image-Guided Therapies,Patient Care Solutions (Monitoring, Cardiology, Maternal Infant, Anesthesia, Digital), |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnosis & Treatment (Imaging and Image-Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory Care),Personal Health, |
| HYLAND SOFTWARE, INC. | United States | Private Company | OnBase platform (ECM, workflow, case management),Healthcare imaging and interoperability (Hyland Healthcare, Acuo, NilRead, PACSgear, Mackinac),Legacy ECM/BPM suites (Perceptive Content, Perceptive Process, Saperion, NolijWeb), |
| ASPYRA, LLC | United States | Public Company | Laboratory information and workflow solutions,Imaging and orthopedic workflow solutions,Hardware, integration, and professional services, |
AGFA-GEVAERT GROUP
Agfa-Gevaert Group is a Belgian public company established in 1867 with 4,211 employees, operating across imaging and healthcare technology sectors.
FUJIFILM HOLDINGS CORPORATION
Fujifilm Holdings Corporation is a Japanese public company founded in 1934 with 73,526 employees, engaged in imaging, healthcare, and materials technology.
SECTRA AB
Sectra AB is a Swedish public company established in 1957 with 1,365 employees, specializing in medical imaging and cybersecurity solutions.
GE HEALTHCARE
GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees, providing medical imaging and healthcare technology solutions.
KONINKLIJKE PHILIPS N.V.
Koninklijke Philips N.V. is a Dutch multinational public company established in 1891 with 64,317 employees, operating in healthcare, lighting, and consumer electronics.
HYLAND SOFTWARE, INC.
Hyland Software, Inc. is a United States private company established in 1991 with 336 employees, developing content management and workflow automation solutions.
ASPYRA, LLC
Aspyra, LLC is a United States public company founded in 1978 with 70 employees, specializing in healthcare imaging and information management systems.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuations ($186.1M in 2026, $317.3M in 2031) and verified 11.3% CAGR to support investment decisions, business planning, and competitive positioning in China's high-growth healthcare IT segment.
- China-Specific Strategic Insights : Access detailed analysis of China's unique regulatory environment, government healthcare policies, and digital transformation initiatives that directly influence VNA and PACS adoption rates and vendor strategies.
- Competitive Landscape Intelligence : Understand vendor positioning, market share dynamics, and competitive strategies specific to China's healthcare IT market, enabling informed go-to-market planning and partnership development.
- Regional Expansion Roadmap : Identify tier-1, tier-2, and tier-3 city opportunities, hospital network penetration rates, and adoption patterns to prioritize market entry and resource allocation across China's diverse healthcare infrastructure.
- Technology Trend Analysis : Gain insights into cloud-based PACS adoption, AI integration, interoperability standards, and emerging technologies shaping China's medical imaging ecosystem to align product development and innovation strategies.
Frequently asked questions
What is the current market size of VNA & PACS in China?
China's VNA & PACS market was valued at $186.1 million in 2026 and is expected to grow to $317.3 million by 2031.
What is the growth rate for China's VNA & PACS market?
China's VNA & PACS market is growing at a compound annual growth rate (CAGR) of 11.3% from 2026 to 2031.
What factors are driving growth in China's VNA & PACS market?
Key drivers include government healthcare digitalization mandates, interoperability requirements, large patient populations, and the shift toward cloud-based imaging infrastructure in China.
Who are the main competitors in China's VNA & PACS market?
China's market includes both international vendors and domestic healthcare IT companies adapting solutions to meet local regulatory and clinical workflow requirements.
How does China's VNA & PACS market growth compare to global trends?
China's 11.3% CAGR significantly exceeds the global market CAGR of 8.9%, reflecting accelerated digital health adoption and infrastructure investment in China.
RESEARCH METHODOLOGY
The study involved five major activities to estimate the current size of the VNA & PACS market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for the study of the VNA PACS market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the VNA & PACS market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
BREAKDOWN OF PRIMARIES
Note 2: Tiers of companies are defined based on their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the VNA & PACS market. These methods were also used extensively to estimate the size of various subsegments in the market.
Data Triangulation
After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and determine the exact statistics for each market segment and sub-segment, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the VNA & PACS market.
Market Definition
VNA and PACS are medical imaging technologies that offer cost-effective storage and easy access to images from various modalities. These solutions are essential elements of modern healthcare IT infrastructure, enabling the efficient and secure digitization, storage, retrieval, and sharing of medical imaging data.
Key Stakeholders
- VNA & PACS vendors
- Government bodies
- Healthcare service providers
- Clinical/Physician centers
- Healthcare professionals
- Health IT service providers
- Healthcare associations/institutes
- Ambulatory care centers
- Venture capitalists
- Distributors and resellers
- Maintenance and support service providers
- Integration service providers
- Healthcare players
Report Objectives
- To define, describe, and forecast the VNA & PACS market based on product type, modality, deployment, vendor type, application, end user, and region
- To provide detailed information regarding the factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets¹ with respect to individual growth trends, prospects, and contributions to the market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies²
- To track and analyze competitive developments such as product launches and approvals; joint ventures, partnerships, & collaborations; acquisitions; and contracts in the VNA & PACS market.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
- Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
- Geographic Analysis: Further breakdown of Latin America, Europe, and the Middle East & Africa VNA & PACS into specific countries
Get the Full Vendor Neutral Archive (VNA) & PACS Market Report
Full forecast, segment splits, and company analysis for all Vendor Neutral Archive (VNA) & PACS Market.
- US Vendor Neutral Archive (VNA) & PACS Market
- Canada Vendor Neutral Archive (VNA) & PACS Market
- UK Vendor Neutral Archive (VNA) & PACS Market
- Germany Vendor Neutral Archive (VNA) & PACS Market
- France Vendor Neutral Archive (VNA) & PACS Market
- Italy Vendor Neutral Archive (VNA) & PACS Market
- Spain Vendor Neutral Archive (VNA) & PACS Market
- Japan Vendor Neutral Archive (VNA) & PACS Market
- India Vendor Neutral Archive (VNA) & PACS Market
- Brazil Vendor Neutral Archive (VNA) & PACS Market
- Mexico Vendor Neutral Archive (VNA) & PACS Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report